ClinicalTrials.gg
CompletedNCT04165733Updated Oct 22, 2026

Professional Quality of Life in German Psychiatrists

An observational study in Mental Disorder, Burnout, Caregiver and Burnout, Professional, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Charite University, Berlin, Germany · Observational

How we know

Updated Oct 22, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
87
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess professional quality of life in German psychiatrists working with patients with mental disorders.

Read the detailed description

The purpose of this study is to assess professional quality of life, which includes compassion satisfaction, burnout and secondary traumatization in psychiatrists, working with patients with mental disorders, in Germany.

02

Conditions studied

  • Mental Disorder
  • Burnout, Caregiver
  • Burnout, Professional

Keywords

  • Professional quality of life
  • Compassion satisfaction
  • Burnout
  • Psychiatrists
  • Mental disorders
  • Mental health
03

In context

Mental Disorders

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's enrollment of 87 is below the median of 220 across 391 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Psychiatrists (already specialzied in psychiatry or currently in specialization for psychiatry) that currently work with patients with mental disorders in Germany.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Psychiatrits (Physician with specialization in psychiatry or currently in specialization for psychiatry)
  • Currently working with patients with mental disorders
  • At least 18 years old
  • Sufficient German skills for answering the questionnaire

Exclusion criteria

Exclusion Criteria:

None

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
87 participants (actual)
Patient registry
No

Groups and cohorts

  • Psychiatrists in Germany

    Psychiatrists in Germany currently working with patients with mental disorders

    Diagnostic Test: Online questionnaire

Interventions

  • Diagnostic testOnline questionnaire

    Clinical psychologists in Germany currently working with patients with mental disorders

06

What researchers measure

Primary outcomes

  1. Compassion Satisfaction

    Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Compassion Satisfaction" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher compassion satisfaction.

    Time frame: 1 day

  2. Burnout

    Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Burnout" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of burnout.

    Time frame: 1 day

  3. Traumatization

    Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Secondary Traumatization" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of secondary traumatization.

    Time frame: 1 day

07

Study locations

1 site
  • Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte
    Berlin, State of Berlin 10117, Germany
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jan 2020 to primary completion in Oct 2026, 81 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: primary completion Dec 2026 → Oct 2026 and completion Dec 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2019
First posted
Nov 18, 2019
StartActual
Jan 16, 2020
Primary completionActual
Oct 20, 2026was Dec 2026
CompletionActual
Oct 20, 2026was Dec 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Suspended→Completed Reason for stopping removed
changed Oct 22, 2026
Sites
1 site added, 1 site removed
Show site
  • Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte · Berlin, Germany
Show 1 removed
  • Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte · Berlin, Germany
Oct 22, 2026
Primary completion
Dec 2026→Oct 20, 2026 (actual)
Oct 22, 2026
Study completion
Dec 2026→Oct 20, 2026 (actual)
Oct 22, 2026
Enrollment
100 (estimated)→87 (actual)
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Suspended→Completed
    Why stopped Reason for stopping removed
    1 site added, 1 site removed
    Show site
    • Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte · Berlin, Germany
    Show 1 removed
    • Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte · Berlin, Germany
    Primary completion Dec 2026→Oct 20, 2026 (now actual)
    Study completion Dec 2026→Oct 20, 2026 (now actual)
    Enrollment 100 (estimated)→87 (actual)
    + 4 other changes: index terms, identifiers, verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04165733
Responsible party
Moritz Petzold (Principal Investigator, Charite University, Berlin, Germany) — Principal investigator
First posted
Nov 18, 2019
Start date
Jan 16, 2020
Primary completion
Oct 20, 2026
Completion
Oct 20, 2026
Last update
Oct 22, 2026

Study contacts

Moritz B Petzold, Dipl.-Psych.
principal investigator · Charité Universitätsmedizin Berlin- Charité Campus Mitte - Department for Psychiatry and Psychotherapy

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion